updated 5/10/2010 4:48:31 PM ET 2010-05-10T20:48:31

Medical device maker Alphatec Holdings Inc. posted a larger first-quarter loss on Monday as it completed the purchase of Scient'x Groupe SAS.

The parent of Alphatec Spine said it lost $4.7 million, up from $4.4 million a year ago. Because the company now has more stock on the market, its per-share loss was unchanged at 9 cents. Excluding costs related to the Scient'x deal and restructuring costs, the company said it lost $200,000 — or broke even on a per-share basis.

Analysts were expecting a loss of 2 cents per share, according to Thomson Reuters.

Alphatec said its revenue grew 26 percent, to $38.4 million from $30.6 million. U.S. sales were up 19 percent to $28.4 million, and European sales rose to $3.9 million from $1 million. Analysts had expected $38.2 million in revenue.

The company reported $3.2 million in transaction costs and $882,000 in restructuring costs during the quarter. It also said research and development spending rose by $1 million, to $3.7 million.

Alphatec said it expects $220 million to $225 million in revenue this year, in line with its previous forecast. Analysts are projected $205.1 million on average.

Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com